Could a dye-and-radiation combo spare ovarian cancer patients from extensive lymph node removal?
NCT ID NCT05937620
First seen Feb 14, 2026 · Last updated Jun 14, 2026 · Updated 21 times
Summary
This study tests whether a combination of a radioactive tracer and a green dye can accurately identify the first lymph nodes that ovarian cancer may spread to. About 62 women with early-stage ovarian cancer will receive both tracers before surgery. If successful, this approach could allow surgeons to remove only the key lymph nodes instead of many, reducing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN EPITHELIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Laura Burunat
RECRUITINGBarcelona, Catalonia, 08036, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.